Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder

Journal of Psychiatric Research

Volumn 47, Issue 11, 2013, Pages 1831-1834

  Kandemir, Hasan ^a   Abuhandan, Mahmut ^a   Aksoy, Nurten ^a   Savik, Emin ^b   Kaya, Cemil ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Sanliurfa Childrens' Hospital   (Turkey)

Author keywords

Child and adolescent obsessive compulsive disorder; Oxidative stress; Oxidative stress index; Total antioxidative status; Total oxidative status

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD AND ADOLESCENT OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; TOTAL ANTIOXIDATIVE STATUS; TOTAL OXIDATIVE STATUS;

ADOLESCENT; ANTIOXIDANTS; CHILD; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; OXIDANTS; OXIDATIVE STRESS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84884417063     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.08.010     Document Type: Article

References (51)

1. Akyol O., Zoroglu S.S., Armutcu F., Sahin S., Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. InVivo 2004, 18(3):377-390.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, 4th, Text-Revision(DSM-IV-TR), American Psychiatric Association, Washington, DC.
3. Atmaca M., Tezcan E., Kuloglu M., Ustundag B., Tunckol H. Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. European Archives of Psychiatry and Clinical Neuroscience 2004, 254(4):231-235.
4. Atmaca M., Tezcan E., Kuloglu M., Ustundag B. Plasma nitrate values in patients with obsessive-compulsive disorder. Psychiatry and Clinical Neurosciences 2005, 59(5):621-623.
5. Attari A., Asgary S., Naderi G.A., Rezayat A. Lipid peroxidation and antioxidant capacity in posttraumatic stress disorder. JIsfahan Med Sch 2002, 20:4-6.
6. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1998, 1366:211-223.
7. Behl A., Swami G., Sircar S.S., Bhatia M.S., Banerjee B.D. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology 2010, 61(4):210-214.
8. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. Journal of Affective Disorders 2001, 64:43-51.
9. Bulut M., Selek S., Gergerlioglu H.S., Savas H.A., Yilmaz H.R., Yuce M., et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. Journal of Psychiatry & Neuroscience 2007, 32(6):435-438.
10. Ceylan M., Sener S., Bayraktar A.C., Kavutcu M. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010; 1, 34(8):1491-1494.
11. Ceylan M.F., Sener S., Bayraktar A.C., Kavutcu M. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry and Clinical Neurosciences 2012, 66(3):220-226.
12. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. British Medical Bulletin 1993, 49:481-493.
13. Coskun M., Zoroglu S. Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 2009, 19(3):297-300.
14. Douglass H.M., Moffitt T.E., Dar R., McGee R., Silva P. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. Journal of the American Academy of Child & Adolescent Psychiatry 1995, 34:1424-1431.
15. Dubinina E.E., Prustygina A.V. Free radical processes in aging, neurodegenerative diseases and other pathological states. Biomed Khim 2007, 53(4):351-372.
16. Eckerson H.W., Wyte C.M., La Du B.N. The human serum paraoxonase/arylesterase polymorphism. American Journal of Human Genetics 1983, 35:1126-1138.
17. Erel O. Anovel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004, 37(2):112-119.
18. Erel O. Anew automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005, 38(12):1103-1111.
19. Ersan S., Bakir S., Erdal Ersan E., Dogan O. Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006 30, 30(6):1039-1042.
20. Ersoy M.A., Selek S., Celik H., Erel O., Kaya M.C., Savas H.A., et al. Role of oxidative and antioxidative parameters in etiopathogenesis and prognosis of panic disorder. International Journal of Neuroscience 2008, 118(7):1025-1037.
21. Flament M.F., Whitaker A., Rapoport J.L., Davies M., Berg C.Z., Kalikow, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. Journal of the American Academy of Child & Adolescent Psychiatry 1998, 27:764-771.
22. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., et al. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007; 30, 31(1):283-285.
23. Garcia A.M., Freeman J.B., Himle M.B., Berman N.C., Ogata A.K., Ng J., et al. Phenomenology of early childhood onset obsessive compulsive disorder. Journal of Psychopathology and Behavioral Assessment 2009, 31(2):104-111.
24. Gökler B., Ünal F., Pehlivantürk B., Kultur E.C., Akdemir D., Taner Y. Schedule for affective disorders and schizophrenia for school-age children present and lifetime version - the validity and reliability of adaptation in Turkish. Turkish Journal of Child and Adolescent Mental Health 2004, 11:109-116.
25. Grisham J.R., Fullana M.A., Mataix-Cols D., Moffitt T.E., Caspi A., Poulton R. Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. Psychological Medicine 2011, 15:1-12.
26. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinical Chemistry 1995, 41:1819-1828.
27. Haagen L., Brock A. Anew automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. European Journal of Clinical Chemistry and Clinical Biochemistry 1992, 30:391-395.
28. Herken H., Akyol O., Yilmaz H.R., Tutkun H., Savas H.A., Ozen M.E., et al. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Human Psychopharmacology 2006, 21(1):53-59.
29. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Archives of Medical Research 2007, 38(2):247-252.
30. Hollander E., Simeon D. Obsessive-compulsive disorder. Essentials of clinical psychiatry 2004, 377-379. American Psychiatric Publishing Inc, Washington, DC. R.E. Hales, S.C. Yudofsky (Eds.).
31. Iervolino A.C., Rijsdijk F.V., Cherkas L., Fullana M.A., Mataix-Cols D. Amultivariate twin study of obsessive-compulsive symptom dimensions. Archives of General Psychiatry 2011, 68(6):637-644.
32. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for affectivedisorders and schizophrenia for school-age children present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry 1997, 36:980-988.
33. Kern J.K., Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. Journal of Toxicology and Environmental Health, Part B Critical Reviews 2006, 9:485-499.
34. Kosecik M., Erel O., Sevinc E., Selek S. Increased oxidative stress in children exposed to passive smoking. International Journal of Cardiology 2005, 100:61-64.
35. Kuloglu M., Atmaca M., Tezcan E., Gecici O., Tunckol H., Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 2002, 46:27-32.
36. Leckman J.F., Bloch M.H., King R.A. Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective dialogues. Clinical Neuroscience 2009, 11(1):21-33.
37. Li W.F., Costa L.G., Furlong C.E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. Journal of Toxicology and Environmental Health 1993, 40:337-346.
38. Mahadik S.P., Mukharjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophrenia Research 1996, 19:1-17.
39. Micó J.A., Rojas-Corrales M.O., Gibert-Rahola J., Parellada M., Moreno D., Fraguas D., et al. Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry 2011; 14, 11:26.
40. Orhan N., Kucukali C.I., Cakir U., Seker N., Aydin M. Genetic variants in nuclear-encoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders. Journal of Psychiatric Research 2012, 46(2):212-218.
41. Parellada M., Moreno C., Mac-Dowell K., Leza J.C., Giraldez M., Bailón C., et al. Plasma antioxidant capacity is reduced in Asperger syndrome. Journal of Psychiatric Research 2012, 46(3):394-401.
42. Pauls D.L., Alsobrook J.P., Goodman W., Rasmussen S., Leckman J.F. Afamily study of obsessive-compulsive disorder. American Journal of Psychiatry 1995, 152:76-84.
43. Rajasekaran K. Seizure-induced oxidative stress in rat brain regions: blockade by nNOS inhibition. Pharmacology Biochemistry and Behavior 2005, 80(2):263-272.
44. Scahill L., Riddle M.A., McSwiggin-Hardin M., Ort S.I., King R.A., Goodman W.K., et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. Journal of the American Academy of Child & Adolescent Psychiatry 1997, 36:844-852.
45. Selek S., Herken H., Bulut M., Ceylan M.F., Celik H., Savas H.A., et al. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008; 15, 32(2):487-491.
46. Selek S., Bulut M., Ocak A.R., Kalenderoǧlu A., Savaş H.A. Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. Journal of Psychiatric Research 2012, 46(4):451-455.
47. Serafini M., Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?. Redox Report 2004, 9(3):145-152.
48. Sögüt S., Zoroglu S.S., Ozyurt H., Yimaz H.R., Ozugurlu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clinica Chimica Acta 2003, 331:111-117.
49. Tezcan E., Atmaca M., Kuloglu M., Ustundag B. Free radicals in patients with post-traumatic stress disorder. European Archives of Psychiatry and Clinical Neuroscience 2003, 253:89-91.
50. Yucelen A.G., Rodopman-Arman A., Topcuoglu V., Yazgan M.Y., Fisek G. Interrater reliability and clinical efficacy of children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Comprehensive Psychiatry 2006, 47(1):48-53.
51. Yumru M., Savas H.A., Kalenderoglu A., Bulut M., Celik H., Erel O. Oxidative imbalance in bipolar disorder subtypes: a comparative study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009 31, 33(6):1070-1074.